Previous 10 | Next 10 |
Nes-Ziona, Israel, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd., a clinical-stage immunotherapy company, today announced that the China National Intellectual Property Administration (CNIPA) issued a notice of allowance for a new patent application covering ALLOCETRA ...
Moxian (NASDAQ: MOXC ) +52% on merger with Btab . More news on: Moxian, Inc., VBI Vaccines Inc., ZAGG Inc, Stocks on the move, , Read more ...
Nes-Ziona, Israel, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd., a clinical-stage immunotherapy company, today announced that the U.S. Patent and Trademark Office issued a notice of allowance for a new patent application covering ALLOCETRA TM , the company’s immu...
The first patient has been dosed in an investigator-initiated study evaluating Enlivex Therapeutics' (NASDAQ: ENLV ) Allocetra, on top of standard-of-care treatment, in severely ill COVID-19 patients with respiratory failures. More news on: Enlivex Therapeutics Ltd., Healthcare stocks ...
Seres Therapeutics (NASDAQ: MCRB ) +266% on success of lead drug in C. diff study. More news on: Seres Therapeutics, Inc., Trevena, Inc., Hoth Therapeutics, Inc., Stocks on the move, , Read more ...
Nes Ziona, Israel, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that the first patient has been dosed in an investigator-initiated multi-center clinical trial of Allocetra TM in COVID-19 patients with ...
- D ata show a 90% decrease in mortality with Allocetra TM treatment in a murine cecal ligation and puncture severe sepsis model Nes Ziona, Israel, July 20, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced the...
Gainers: Polar Power (NASDAQ: POLA ) +69% . More news on: Polar Power, Inc., Blink Charging Co., Carver Bancorp, Inc., Stocks on the move, , Read more ...
Nes-Ziona, Israel, June 18, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics, Ltd., a clinical-stage immunotherapy company, today announced that the Japan Patent Office (JPO) has issued a notice of allowance for a patent application covering ALLOCETRA TM , the company’s immunotherapy ...
Nes Ziona, Israel, June 01, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that management will present a corporate overview at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020, at 8:00 AM ET....
News, Short Squeeze, Breakout and More Instantly...
Enlivex Therapeutics Ltd. Company Name:
ENLV Stock Symbol:
NASDAQ Market:
Enlivex Therapeutics Ltd. Website:
• First study of Allocetra TM in psoriatic arthritis, a chronic inflammatory condition that causes joint pain, swelling and stiffness, affects as many as 30% of people with psoriasis 1 , and has limited treatment options Nes-Ziona, Israel, July 23, 2024 (GLOB...
ORLANDO, FL / ACCESSWIRE / July 19, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 20, at 7 p.m. Eastern T...
First patient dosed with Allocetra TM in thumb osteoarthritis, a degenerative, debilitating and progressive disease that affects millions of people Thumb osteoarthritis currently has no FDA-approved therapy and no effective long-term treatments Ness-Ziona, Israel, June 24, 2024 (GLO...